ClinicalTrials.Veeva

Menu

Social COgnition Screening (ECoS-A)

C

Centre Hospitalier Universitaire, Amiens

Status

Not yet enrolling

Conditions

Autism Spectrum Disorder
Diagnosis
Eye-tracking
Social Cognition

Treatments

Other: eye-tracking
Other: cognitive assessments

Study type

Interventional

Funder types

Other

Identifiers

NCT07377227
PI2025_843_0181

Details and patient eligibility

About

Social cognition refers to the mental processes involved in social interactions, including social perception, motivation, communication, emotion recognition, and theory of mind. Face perception plays a key role in children's social development, but children with Autism Spectrum Disorder (ASD) tend to look less at social stimuli, especially faces, than typically developing (TD) peers. Eye-tracking studies highlight these visual exploration differences, linked to difficulties in joint attention, emotion recognition, and theory of mind, as well as in executive and memory functions. Standard diagnostic tests often require active participation and sufficient language, which makes assessment challenging for children with ASD and additional cognitive or language impairments.

This research project investigates how visual activity supports social cognition depending on cognitive and language levels, hypothesizing that eye-tracking can provide useful indicators for ASD screening and diagnosis.

Enrollment

128 estimated patients

Sex

All

Ages

4 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASD Group:
  • Boys or girls diagnosed with Autism Spectrum Disorder (based on clinical tools and observations)
  • Aged between 4 and 10 years old
  • Affiliation with a social security scheme
  • Informed consent of those with parental authority
  • DT Group:
  • Boys or girls
  • Aged between 4 and 10
  • Attending school in the Hauts-de-France region
  • Affiliation with a social security scheme
  • Consent of those with parental authority

Exclusion criteria

  • For ASD: Uncorrected visual or auditory impairments.
  • For DT: Intellectual disability, neurological or genetic disorders, autistic traits reported by teachers. The discrepancy between actual age and abilities calculated on the basis of standardised test scores

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

128 participants in 2 patient groups

ASD
Experimental group
Description:
Autism Spectrum Disorder
Treatment:
Other: cognitive assessments
Other: eye-tracking
DT
Active Comparator group
Description:
typically developing (TD) peers
Treatment:
Other: cognitive assessments
Other: eye-tracking

Trial contacts and locations

1

Loading...

Central trial contact

Federica Cilia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems